Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Refine results:

Refine results

Webinars on demand

Outside the Lab Oncology

Implementing the 2017 WHO Cancer Resolution: Time to acknowledge the critical role of pathology & laboratory medicine services?

In 2012, cancer was the second leading cause of mortality in the world with 8.2 million cancer-related deaths.

Inside the Lab Digital and computational pathology

The Role of Artificial Intelligence in Digital Pathology

| Sponsored by Leica

During this webinar, Dr. Cornish will present the unique perspectives of a practicing pathologist on the emerging field of Computational Pathology and Artificial Intelligence.

Diagnostics Precision medicine

Laser Microdissection in Clinical Practice

| Sponsored by Leica

Impact on KRAS/NRAS/EGFR Mutation Analysis and Personalized Cancer Treatment

Inside the Lab Digital and computational pathology

Digital Pathology: Experiences in Implementation from North Wales NHS

| Sponsored by Leica

The merging of three North Wales hospital pathology departments formed one of the largest labs in the country, serving a population of 700,000.

Outside the Lab Digital and computational pathology

The Benefits of Computational Pathology

| Sponsored by Philips

Is there a need for computational pathology in hospitals today? Are current hospital technologies ready for the change?

Inside the Lab Liquid biopsy

Advancing liquid biopsy research using next-generation sequencing: A multi-centre lung cancer cell-free DNA (cfDNA) study

| Sponsored by Thermo Fisher Scientific

Tumour-specific mutations in plasma can serve as biomarkers for tumour detection, monitoring tumour response to therapies, detecting residual disease, and enabling long-term follow-up.

Diagnostics Histology

Large Volume Imaging: Tips and Tricks for Sample preparation and clearing.

| Sponsored by Andor

What can you expect from a successful protocol?

Diagnostics Oncology

Elucidating Tumor Heterogeneity in Prostate Cancer by Combined IHC & Novel RNA ISH

| Sponsored by ACD

Assessment of molecular heterogeneity in tumor is a challenging task. For the first time, Palanisamy et al. have demonstrated the existence of a rare subset of prostate cancer with heterogeneous molecular aberrations involving ETS family genes and SPINK1 expression utilizing both standard immunohistochemistry (IHC) and RNA in situ hybridization (Advanced Cell Diagnostics RNAscope® Technology).

Diagnostics Biochemistry and molecular biology

Clinical Mass Spectrometry: Fundamentals, benefits and applications

| Sponsored by Sciex

Over the last 10 years Liquid Chromatography Mass Spectrometry (LC/MS/MS) has been adopted by many clinical laboratories and been successfully implemented as the technology has become more robust, reliable and affordable

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register